Previous Article | Next Article ![]()
Infection and Immunity, July 2000, p. 4189-4199, Vol. 68, No. 7
Department of Microbiology and
Immunology1 and Division of Infectious
Diseases, Department of Medicine,3 School
of Medicine, University of California, Los Angeles, California 90095, and Department of Medical Microbiology and Immunology,
Texas A&M University, College Station, Texas 778432
Received 3 February 2000/Returned for modification 8 March
2000/Accepted 10 April 2000
In this study, infection-derived immunity in the rabbit model of
Lyme disease was compared to immunity following immunization with
purified outer membrane vesicles (OMV) isolated from Borrelia burgdorferi and recombinant outer surface protein A (OspA).
Immunization of rabbits with OMV isolated from virulent strain B31 and
its avirulent derivative B313 (lacking OspA and DbpA) conferred highly significant protection against intradermal injection with 6 × 104 in vitro-cultivated virulent B. burgdorferi. This is the first demonstration of protective
immunogenicity induced by OMV. While immunization with OspA and
avirulent B31 OMV provided far less protection against this challenge,
rabbits with infection-derived immunity were completely protected.
Protection against host-adapted B. burgdorferi was assessed
by implantation of skin biopsies taken from rabbit erythema migrans (a
uniquely rich source of B. burgdorferi in vertebrate
tissue) containing up to 108 spirochetes. While all of the
OMV- and OspA-immunized rabbits were fully susceptible to skin and
disseminated infection, rabbits with infection-derived immunity were
completely protected. Analysis of the antibody responses to outer
membrane proteins, including DbpA, OspA, and OspC, suggests that the
remarkable protection exhibited by the infection-immune rabbits is
due to antibodies directed at antigens unique to or markedly
up-regulated in host-adapted B. burgdorferi.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Comparison of Protection in Rabbits against Host-Adapted and
Cultivated Borrelia burgdorferi following
Infection-Derived Immunity or Immunization with Outer Membrane
Vesicles or Outer Surface Protein A
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, UCLA School of Medicine, 10833 Le Conte Ave. CHS 43-239, Los Angeles, CA 90095. Phone: (310) 825-4188 (Ellen S. Shang) or (310) 825-1979 (James N. Miller). Fax: (310) 267-2265. E-mail: eshang{at}microimmun.medsch.ucla.edu (Ellen S. Shang) or jmiller{at}microimmun.medsch.ucla.edu (James N. Miller).
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»